Amgen cholesterol drug Repatha bags FDA approval for preventing heart attack and stroke

Check out Repatha FDA approval news where we will tell you about the approval of the Amgen cholesterol drug for the prevention of heart attack and stroke.

Amgen cholesterol drug Repatha bags FDA approval for preventing heart attack and stroke

Repatha FDA approval news : Repatha (evolocumab), the Amgen cholesterol drug has bagged the approval from the US Food and Drug Administration (FDA) for the prevention of heart attacks, strokes and coronary revascularizations in heart disease patients. The Amgen cholesterol injection is a human monoclonal antibody which has been designed to block the activities of […]

Tigenix’ heart attack stem cell therapy trial delivers positive results

European cell therapy company TiGenix has announced positive top-line results for its cardiac stem cell trial evaulating its heart attack stem cell therapy AlloCSC-01 in patients facing the risk of getting heart failure after a coronary attack.

Tigenix’ heart attack stem cell therapy trial delivers positive results

TiGenix has announced that its cardiac stem cell study assessing its heart attack stem cell therapy with AlloCSC-01 was successful in patients having the risk of heart failure following a coronary attack. Tigenix Heart Attack Stem Cell Therapy with AlloCSC-01 The Belgium biopharma stated that its Phase I/II study of donor-derived expanded cardiac stem cells (AlloCSC) […]